BCL2 and cancer: The formed 99mtechnetium-coupled TFOs also bind to the TTS to form stable triplexes and inhibit bcl-2 gene transcription in vitro, indicating that TFOs are a promising carrier for gene-radiotherapy and may provide an additional therapeutic method for cancers with bcl-2 overexpression (Shen et al., 2003).